 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 3004-------------------------------------------------- |
|
(Abst.) Adverse event profile differences between Rituxan and Oc |
|
revus... |
|
By: agate Date: August 25, 2020, 1:21 am |
|
--------------------------------------------------------- |
|
From Multiple Sclerosis Journal (August 24, 2020), "Adverse |
|
event profile differences between rituximab and ocrelizumab: |
|
Findings from the FDA Adverse Event Reporting Database": |
|
https://journals.sagepub.com/doi/abs/10.1177/1352458520949986 |
|
#Post#: 3006-------------------------------------------------- |
|
(MS News Today) MS infection risk for Ocrevus higher than Rituxa |
|
n but cancer risk lower |
|
By: agate Date: August 26, 2020, 11:25 pm |
|
--------------------------------------------------------- |
|
More on this in Multiple Sclerosis News Today (August 26, |
|
2020)--"MS infection risk for Ocrevus higher than Rituximab but |
|
cancer risk lower": |
|
https://bit.ly/2YDIxmm |
|
***************************************************** |
